Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drugs

Showing results (201-210 of 8,369) with videos related to

Pageof 837
Sort By:
Drugs|August 11, 2023
Delandistrogene Moxeparvovec: First ApprovalSheridan M Hoy
Drugs|October 16, 2023
Lotilaner Ophthalmic Solution 0.25%: First ApprovalYahiya Y Syed
Drugs|September 26, 2023
Befotertinib: First ApprovalHannah A Blair
Drugs|July 18, 2023
Fezolinetant: First ApprovalArnold Lee
Drugs|July 24, 2023
Sovateltide: First ApprovalSusan J Keam
Drugs|July 11, 2023
Beremagene Geperpavec: First ApprovalSohita Dhillon
Drugs|July 12, 2023
Omalizumab in Severe Asthma: Effect on Oral Corticosteroid Exposure and Remodeling. A Randomized Open-Label Parallel StudyChristian Domingo, Rosa M Mirapeix, Francisco-Javier González-Barcala, et al.
Drugs|July 12, 2023
Direct-Acting Antivirals and the Risk of Arrhythmias and Conduction Disorders in Patients with Chronic Hepatitis C: A French Nationwide Cohort StudyLaurent Lam, Stanislas Pol, Ariel Cohen, et al.
Drugs|June 27, 2023
Efbemalenograstim Alfa: First ApprovalHannah A Blair
Drugs|March 27, 2003
DTPa-HBV-IPV/Hib vaccine (Infanrix hexa)Monique P Curran, Karen L Goa
Pageof 837

Showing results (201-210 of 8,369) with videos related to

Sort By:
Pageof 837
Drugs|August 11, 2023
Delandistrogene Moxeparvovec: First ApprovalSheridan M Hoy
Drugs|October 16, 2023
Lotilaner Ophthalmic Solution 0.25%: First ApprovalYahiya Y Syed
Drugs|September 26, 2023
Befotertinib: First ApprovalHannah A Blair
Drugs|July 18, 2023
Fezolinetant: First ApprovalArnold Lee
Drugs|July 24, 2023
Sovateltide: First ApprovalSusan J Keam
Drugs|July 11, 2023
Beremagene Geperpavec: First ApprovalSohita Dhillon
Drugs|July 12, 2023
Omalizumab in Severe Asthma: Effect on Oral Corticosteroid Exposure and Remodeling. A Randomized Open-Label Parallel StudyChristian Domingo, Rosa M Mirapeix, Francisco-Javier González-Barcala, et al.
Drugs|July 12, 2023
Direct-Acting Antivirals and the Risk of Arrhythmias and Conduction Disorders in Patients with Chronic Hepatitis C: A French Nationwide Cohort StudyLaurent Lam, Stanislas Pol, Ariel Cohen, et al.
Drugs|June 27, 2023
Efbemalenograstim Alfa: First ApprovalHannah A Blair
Drugs|March 27, 2003
DTPa-HBV-IPV/Hib vaccine (Infanrix hexa)Monique P Curran, Karen L Goa
Pageof 837